A Study Comparing Aczone® Plus Differin® Versus Duac® Plus Differin® in Patients With Severe Facial Acne

• Status: Completed
• Trial end date: 2011-06-01
• Target enrollment: 0
• Participant gender: Female

Summary

A study comparing the topical application of Aczone® plus Differin® versus Duac® plus Differin® in patients with severe facial acne (facial acne vulgaris).

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Allergan
• Treatments: Adapalene; Benzoyl Peroxide; Clindamycin; Clindamycin palmitate; Clindamycin phosphate; Dapsone

Criteria

Inclusion Criteria:

• Severe facial acne (acne vulgaris)

Exclusion Criteria:

• History of significant anemia or hemolysis

• History of enteritis (eg, regional enteritis, ulcerative colitis, pseudomembranous colitis, antibiotic-associated colitis)

• History of lupus, rosacea, or seborrheic dermatitis